Arcutis Biotherapeutics stock price
아커티스 바이오테라퓨틱스NASDAQ:ARQT · Nasdaq · Healthcare$25.16-0.51%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Arcutis Biotherapeutics last closed at $25.16 (-0.51%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 119.9×. Its overall grade ranks 210 of 739 stocks in Healthcare.
About this company
Arcutis Biotherapeutics last closed at $25.16 (-0.51%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A- · 210/739
Valuation grade F
Related stocks
- OrganonCustomer
Arcutis의 피부질환 치료제 유통·상업화 파트너
- AstraZenecaCompetitor
면역·염증성 피부질환 및 관련 치료 영역에서 경쟁
- Bausch Health CompaniesCompetitor
피부과 처방의약품 시장에서 경쟁
About Arcutis Biotherapeutics
- What technical signals does Arcutis Biotherapeutics (ARQT) have?
- Arcutis Biotherapeutics current technical signals: no active technical signal.
- Is Arcutis Biotherapeutics a cup-and-handle pattern?
- No. Arcutis Biotherapeutics has no valid Cup signal right now.
- What published figures are available for Arcutis Biotherapeutics?
- Market cap: $3.08B. Trailing 12 months PER: 119.9×. Latest quarter PBR: 15.50×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Arcutis Biotherapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy